APA (7th ed.) Citation

Cox, T. M., Drelichman, G., Balwani, M., Burrow, T. A., Lukina, E., Rosenbloom, B., . . . Judith Peterschmitt, M. (2016). Four-year follow-up from the ENCORE trial: A randomized, controlled, non-inferiority study comparing eliglustat to imiglucerase in patients with Gaucher disease type 1 stabilized on enzyme replacement therapy. Molecular Genetics & Metabolism, 117(2), S37. https://doi.org/10.1016/j.ymgme.2015.12.229

Chicago Style (17th ed.) Citation

Cox, Timothy M., Guillermo Drelichman, Manisha Balwani, Thomas Andrew Burrow, Elena Lukina, Barry Rosenbloom, Sebastiaan J.M Gaemers, Jennifer Angell, and M. Judith Peterschmitt. "Four-year Follow-up from the ENCORE Trial: A Randomized, Controlled, Non-inferiority Study Comparing Eliglustat to Imiglucerase in Patients with Gaucher Disease Type 1 Stabilized on Enzyme Replacement Therapy." Molecular Genetics & Metabolism 117, no. 2 (2016): S37. https://doi.org/10.1016/j.ymgme.2015.12.229.

MLA (9th ed.) Citation

Cox, Timothy M., et al. "Four-year Follow-up from the ENCORE Trial: A Randomized, Controlled, Non-inferiority Study Comparing Eliglustat to Imiglucerase in Patients with Gaucher Disease Type 1 Stabilized on Enzyme Replacement Therapy." Molecular Genetics & Metabolism, vol. 117, no. 2, 2016, p. S37, https://doi.org/10.1016/j.ymgme.2015.12.229.